Načítá se...
Cardiotoxicity associated with trastuzumab in normal clinical practice
Objective: To evaluate the incidence of cardiotoxicity associated with treatment with trastuzumab in clinical practice by describing its characteristics, progress, and associated risk factors. Methods: Retrospective observational study of patients with HER2-positive breast cancer treated with trastu...
Uloženo v:
| Vydáno v: | Farmacia Hospitalaria |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sociedad Española de Farmacia Hospitalaria
2009
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=365961791003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|